RACD

10.3100.39%
WH

William Henry Stusnick

Chief Business Officer & COO

Mr. William Henry Stusnick is Chief Business Officer & COO of Research Alliance Corporation V from April 2026. Mr. Stusnick is Chief Operating Officer & Chief Business Officer of Research Alliance Corporation III from February 2026. Mr. Stusnick is the Chief Operating Officer & Chief Business Officer at Research Alliance Corporation IV since April 2026. Mr. Stusnick was Analyst of RA Capital Management, L.P. and has been with RA Capital Management since 2022. He is Director at Kinaset Therapeutics, Inc. since January 2026. He is a board observer for Ambros Therapeutics and Sparrow Pharmaceuticals. He previously served as a board observer for Bluejay Therapeutics (acquired by Mirum Pharmaceuticals) and SpyGlass Pharmaceuticals (Nasdaq: SGP). He was Senior Associate of RA Capital Management, L.P. Prior to RA, he was an Investment Banking Analyst at SVB Leerink. He has B.A. in Economics & Biology from Dartmouth College.

Positions